Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06171152
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2023-12-06
Brief Title:
Study of Liraglutide A Weight Loss Drug in High Risk Obese Participants With Cognitive and Memory Issues
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is for people who have multiple sclerosis acute leukemia in remission or long-COVID and a Body Mass Index over 27 and may struggle with cognitive issues such as remembering information concentrating or making decisions that affect everyday life
By doing this study researchers hope to learn how liraglutide Saxenda a weight loss drug affects levels of a certain disease marker in the body called Brain Derived Neurotrophic Factor BDNF Participation in this research will last about 21 weeks
By doing this study researchers hope to learn how liraglutide Saxenda a weight loss drug affects levels of a certain disease marker in the body called Brain Derived Neurotrophic Factor BDNF Participation in this research will last about 21 weeks
Detailed Description:
This study is for people who have multiple sclerosis acute leukemia in remission or long-COVID and a Body Mass Index over 27 and may struggle with cognitive issues such as remembering information concentrating or making decisions that affect everyday life By doing this study researchers hope to learn how liraglutide Saxenda a weight loss drug affects levels of a certain disease marker in the body called Brain Derived Neurotrophic Factor BDNF
Previous research has shown that liraglutide may help regulate BDNF levels which can be linked to issues with cognitive and mental performance Participation in this research will last about 21 weeks
Previous research has shown that liraglutide may help regulate BDNF levels which can be linked to issues with cognitive and mental performance Participation in this research will last about 21 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None